FI941695A0 - Pneumokokki-pintaproteiini A:n epitooppialueet - Google Patents

Pneumokokki-pintaproteiini A:n epitooppialueet

Info

Publication number
FI941695A0
FI941695A0 FI941695A FI941695A FI941695A0 FI 941695 A0 FI941695 A0 FI 941695A0 FI 941695 A FI941695 A FI 941695A FI 941695 A FI941695 A FI 941695A FI 941695 A0 FI941695 A0 FI 941695A0
Authority
FI
Finland
Prior art keywords
surface protein
epitope regions
pneumococcal surface
pneumococcal
epitope
Prior art date
Application number
FI941695A
Other languages
English (en)
Swedish (sv)
Other versions
FI941695A (fi
Inventor
David E Briles
Janet L Yother
Larry S Mcdaniel
Original Assignee
Uab Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uab Research Foundation filed Critical Uab Research Foundation
Publication of FI941695A0 publication Critical patent/FI941695A0/fi
Publication of FI941695A publication Critical patent/FI941695A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI941695A 1993-04-20 1994-04-13 Pneumokokki-pintaproteiini A:n epitooppialueet FI941695A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4889693A 1993-04-20 1993-04-20

Publications (2)

Publication Number Publication Date
FI941695A0 true FI941695A0 (fi) 1994-04-13
FI941695A FI941695A (fi) 1994-10-21

Family

ID=21957026

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941695A FI941695A (fi) 1993-04-20 1994-04-13 Pneumokokki-pintaproteiini A:n epitooppialueet

Country Status (8)

Country Link
EP (1) EP0622081A3 (fi)
JP (2) JP3245298B2 (fi)
AU (1) AU682018B2 (fi)
CA (1) CA2116261A1 (fi)
FI (1) FI941695A (fi)
IL (1) IL109044A (fi)
NO (1) NO941420L (fi)
ZA (1) ZA941584B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6027734A (en) * 1991-02-15 2000-02-22 Uab Research Foundation Mucosal administration of pneumococcal antigens
US5980909A (en) 1991-02-15 1999-11-09 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US6592876B1 (en) * 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
US5955089A (en) 1993-04-20 1999-09-21 Uab Research Foundation Strain selection of pneumococcal surface proteins
AU734488B2 (en) * 1994-05-20 2001-06-14 Uab Research Foundation Mucosal administration of pneumococcal antigens
ZA964896B (en) * 1995-06-07 1997-01-08 Connaught Lab Expression of lipoproteins
US7078042B2 (en) 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
JP2000511411A (ja) * 1996-05-01 2000-09-05 ザ ロックフェラー ユニヴァーシティ 抗―肺炎球菌ワクチン用のコリン結合タンパク質
US6245335B1 (en) 1996-05-01 2001-06-12 The Rockefeller University Choline binding proteins for anti-pneumococcal vaccines
ES2277362T5 (es) * 1996-10-31 2014-12-18 Human Genome Sciences, Inc. Antígenos y vacunas de streptococcus pneumoniae
CA2269636A1 (en) 1996-11-12 1998-05-22 The Regents Of The University Of Minnesota C3 binding protein of streptococcus pneumoniae
US6676943B1 (en) 1997-04-24 2004-01-13 Regents Of The University Of Minnesota Human complement C3-degrading protein from Streptococcus pneumoniae
EP1073450A4 (en) * 1998-04-23 2003-04-23 Uab Research Foundation PNEUMOCOCCAL SURFACE PROTEIN C (PSPC), EPITOPIC REGIONS, SELECTION OF CORRESPONDING STRES AND USES
ATE361365T1 (de) * 1998-07-27 2007-05-15 Sanofi Pasteur Ltd Streptococcus pneumoniae proteine und nukleinsäuren
US6936252B2 (en) 1998-07-27 2005-08-30 Microbial Technics Limited Streptococcus pneumoniae proteins and nucleic acid molecules
US6869767B1 (en) 1999-06-11 2005-03-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Detection of Streptococcus pneumoniae and immunization against Streptococcus pneumoniae infection
AU4683299A (en) * 1999-06-11 2001-01-02 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Detection of streptococcus pneumoniae and immunization against streptococcus pneumoniae infection
BRPI0109293B8 (pt) * 2000-03-16 2021-05-25 Childrens Hospital Philadelphia métodos para produzir polissacarídeo capsular a partir de um pneumococo, para produzir uma preparação imunogênica para a administração a um animal em risco de desenvolver uma infecção pneumocócica, e para produzir polissacarídeo pneumocócico
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
JPWO2017170494A1 (ja) * 2016-03-29 2019-02-14 国立大学法人 東京大学 抗肥満ワクチン
AU2017366726B2 (en) 2016-12-03 2021-12-09 The Uab Research Foundation Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein A
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA921025B (en) * 1991-02-15 1992-11-25 Uab Research Foundation Structural gene of pneumococcal protein

Also Published As

Publication number Publication date
IL109044A (en) 2000-08-31
CA2116261A1 (en) 1994-10-21
FI941695A (fi) 1994-10-21
EP0622081A3 (en) 1995-11-15
ZA941584B (en) 1994-10-12
NO941420L (no) 1994-10-21
JP2002167399A (ja) 2002-06-11
JP3245298B2 (ja) 2002-01-07
EP0622081A2 (en) 1994-11-02
NO941420D0 (no) 1994-04-19
IL109044A0 (en) 1994-06-24
JPH07126291A (ja) 1995-05-16
AU5769694A (en) 1994-10-27
AU682018B2 (en) 1997-09-18

Similar Documents

Publication Publication Date Title
FI941695A0 (fi) Pneumokokki-pintaproteiini A:n epitooppialueet
DK145493D0 (da) Antistof
DE68902103T2 (de) Faltenbalg.
DE68914244T2 (de) Monoklonaler Antikörper.
FI952444A (fi) Pneumokokin pintaproteiinin A epitooppiset alueet
DE69428362T2 (de) Flächenreissverschlusseinsatzherstellungsverfahren
DE69413586D1 (de) Flächenreissverschlussteil
DE59407063D1 (de) Deodorierende zubereitungen
DE69007829D1 (de) Rieselventil.
DE69429514D1 (de) Antiparasitäre präparate
FI940109A0 (fi) Peptidejä
ATE129789T1 (de) Ventiloberteil.
DE59001458D1 (de) Nichtwaessrige kunststoffzubereitungen.
NO910653L (no) Ett-greps blandeventil.
FI890699A (fi) Renin inhiberande aminosyraderivat.
DE58900910D1 (de) Faltenbalg.
DE69211049T2 (de) Sanftanlaufventil
IT215751Z2 (it) Valvola di regolazione.
DE69420099D1 (de) Vakuumventil
FI933907A0 (fi) Refraktometri
NO178085C (no) Hovedventil
FI893928A (fi) Monoklonala motkroppar.
DE68912772T2 (de) Monoklonaler antikörper gegen entero-viren.
DE9404993U1 (de) Balg
FR2712371B1 (fr) Raccord souple.

Legal Events

Date Code Title Description
FD Application lapsed